Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate for hospitalized patients with COVID-19
MOH_2020-12-20_009586Phase 3Not yet recruiting
- Sponsor
- Hebrew University of Jerusalem
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fenofibrate in coronavirus disease 2019 (COVID-19) (4 arms), sponsored by Hebrew University of Jerusalem. Planned start Dec 2020; status: not yet recruiting.
02
Drugs
fenofibrate
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on MOH_2020-12-20_009586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-12-20_009586.